Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-22-017396

Principal Accounting Officer sold 220 shares at $12.01 ($2,642)

  • Principal Accounting Officer acquired 41,186 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
PISKEL KYLE Principal Accounting Officer 2022-03-04 Grant or award +41,186 47,885 D
PISKEL KYLE Principal Accounting Officer 2022-03-07 Sale −220 $12.01 $2,642 47,665 D
Derivatives
PISKEL KYLE Principal Accounting Officer 2022-03-04 Grant or award · Stock Option (Right to Buy) +102,965 102,965 D
Open-market sales · 220 sh · avg $12.01 · $2,642
Loading xslF345X03/doc4.xml…